IRLAB to present at Redeye Healthcare Day 2026

Gothenburg, Sweden, April 9, 2026 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson’s disease, today announced that the company will give a presentation at Redeye Health Care Day in Stockholm on April 14.

IRLAB to present clinical and preclinical data at the AD/PD™ 2026 – 20th International Conference on Alzheimer’s & Parkinson’s Diseases

IRLAB participates in Life Science Day in Gothenburg on March 4, 2026